Skip to main content

Table 1 Change of bladder, bowel, vaginal, sexual and psychological symptoms from the preoperative to the postoperative period

From: Functional outcomes of posterior intravaginal slingplasty: report on its impact on urinary, bowel and psychosexual function

DOMAIN

Preoperative symptoms/impact

No preoperative symptoms/impact

Symptoms better

Symptoms worse

No change in symptoms

p*

Urinary (n = 31)

  Voiding

21 (67.74%)

10 (32.2%)

16 (51.61%)

8 (25.8%)

7 (22.58%)

0.120

  Impact of voiding

19 (61.29%)

12 (38.70%)

15 (48.38%)

3 (9.67%)

13 (41.93%)

0.014

  Pain and sensation

20 (64.51%)

11 (35.48%)

12 (38.70%)

6 (19.35%)

13 (41.93%)

0.189

  Impact of pain and sensation

16 (51.61%)

15 (48.38%)

10 (32.2%)

5 (16.12%)

16 (51.61%)

0.122

  Overactive bladder

29 (93.54%)

2 (6.45%)

18 (58.06%)

4 (12.90%)

9 (29.03%)

0.014

  Impact of overactive bladder

25 (80.64%)

6 (19.35%)

17 (54.83%)

3 (9.67%)

11 (35.48%)

0.004

  Stress urinary incontinence

25 (80.64%)

6 (19.35%)

17 (54.83%)

4 (12.90%)

10 (32.2%)

0.002

  Impact of stress incontinence

22 (70.96%)

9 (29.03%)

13 (41.93%)

2 (6.45%)

16 (51.61%)

0.005

  Quality of life

24 (77.41%)

7 (22.5%)

19 (61.29%)

1(3.22%)

11 (35.48%)

0.003

Bowel (n = 31)

  Irritable bowel symptoms

30 (96.77%)

1 (3.22%)

15 (48.38%)

2 (6.45%)

14 (45.16%)

0.047

  Constipation

18 (58.06%)

13 (41.93%)

12 (38.7%)

3 (9.67%)

16 (51.61%)

0.063

  Evacuation

29 (93.54%)

2 (6.45%)

20 (64.51%)

4 (12.90%)

7 (22.58%)

0.014

  Impact of evacuation

26 (83.87%)

5 (16.12%)

13 (41.93%)

2 (6.45%)

16 (51.61%)

0.005

  Continence

31 (100%)

0

19 (61.29%)

2 (6.45%)

10 (32.2%)

0.051

  Impact of continence

24 (77.41%)

7 (22.58%)

14 (45.16%)

1 (3.22%)

16 (51.61%)

0.005

  Quality of life

16 (51.61%)

15 (48.38%)

14 (45.16%)

3 (9.67%)

14 (45.16%)

0.013

Vagina (n = 31)

  Pain

29 (93.54%)

2 (6.45%)

25 (80.64%)

3 (9.67%)

3 (9.67%)

<0.001

  Impact of pain

25 (80.64%)

6 (19.35%)

21 (67.74%)

1 (3.22%)

9 (29.03%)

<0.001

  Prolapse

31 (100%)

0

31 (100%)

0

0

<0.001

  Impact of prolapse

29 (93.54%)

2 (6.45%)

29 (93.54%)

0

2 (6.45%)

<0.001

  Quality of life

29 (93.54%)

2 (6.45%)

27 (87.09%)

1 (3.22%)

3 (9.67%)

<0.001

Sexa (n = 10)

  Sex overall

10 (100%)

0

8 (80%)

0

2 (20%)

0.004

  Sex and bladder

10 (100%)

0

10 (100%)

0

0

0.002

  Impact of sex and bladder

9 (90%)

1 (10%)

8 (80%)

0

2 (20%)

0.002

  Sex and bowel

6 (60%)

4 (40%)

6 (60%)

1 (10%)

3 (30%)

0.096

  Impact of sex and bowel

4 (40%)

6 (60%)

4 (40%)

0

6 (60%)

0.099

  Sex and vagina

9 (90%)

1 (10%)

9 (90%)

0

1 (10%)

0.007

  Impact of sex and vagina

9 (90%)

1 (10%)

8 (80%)

0

2 (20%)

0.002

  Psychological status

30 (96.77%)

1 (3.22%)

29 (93.54%)

0

2 (6.45%)

<0.001

  1. Data expressed as n (%)
  2. *Wilcoxon signed rank test
  3. aAnalysed on sexually active patients (n = 10)